Global Hip Tendinitis Market Growth (Status and Outlook) 2025-2031
Description
The global Hip Tendinitis market size is predicted to grow from US$ 323 million in 2025 to US$ 438 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.
Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Hip Tendinitis Industry Forecast” looks at past sales and reviews total world Hip Tendinitis sales in 2024, providing a comprehensive analysis by region and market sector of projected Hip Tendinitis sales for 2025 through 2031. With Hip Tendinitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hip Tendinitis industry.
This Insight Report provides a comprehensive analysis of the global Hip Tendinitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hip Tendinitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hip Tendinitis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hip Tendinitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hip Tendinitis.
This report presents a comprehensive overview, market shares, and growth opportunities of Hip Tendinitis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Internal Snapping Hip
External Snapping Hip
Intra-articular Snapping Hip
Segmentation by Application:
Hospitals & Clinics
Medical Research Centers
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Almatica Pharma
AstraZeneca
Bayer
Boehringer Ingelheim Pharmaceuticals
Merck & Co.
Pfizer
Abbott
GlaxoSmithKline
Teva Pharmaceuticals
Lupin Pharmaceuticals
Geri-Care Pharmaceuticals
Perrigo Company
Please note: The report will take approximately 2 business days to prepare and deliver.
Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Hip Tendinitis Industry Forecast” looks at past sales and reviews total world Hip Tendinitis sales in 2024, providing a comprehensive analysis by region and market sector of projected Hip Tendinitis sales for 2025 through 2031. With Hip Tendinitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hip Tendinitis industry.
This Insight Report provides a comprehensive analysis of the global Hip Tendinitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hip Tendinitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hip Tendinitis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hip Tendinitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hip Tendinitis.
This report presents a comprehensive overview, market shares, and growth opportunities of Hip Tendinitis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Internal Snapping Hip
External Snapping Hip
Intra-articular Snapping Hip
Segmentation by Application:
Hospitals & Clinics
Medical Research Centers
Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Almatica Pharma
AstraZeneca
Bayer
Boehringer Ingelheim Pharmaceuticals
Merck & Co.
Pfizer
Abbott
GlaxoSmithKline
Teva Pharmaceuticals
Lupin Pharmaceuticals
Geri-Care Pharmaceuticals
Perrigo Company
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Hip Tendinitis Market Size by Player
- 4 Hip Tendinitis by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Hip Tendinitis Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
